Skip to main content

Leveraging in vivo phenotypic screens for novel target discovery in neurological disorders

24 Jun 2024
Salon A
Novel Targets
  • Unbiased, phenotype-driven drug discovery to identify most potent novel targets benchmarked against other targets & existing therapies
  • Novel target discovery in in vivo animal models vs. in vitro cell-based experiments
  • Translatability of novel targets of phenotypic screens into clinic
  • Generating complementary in vivo and in vitro neuropharmacology datasets to inform clinical trial designs
Industry Expert
Shane Hegarty, CSO - Axonis Therapeutics